AR246745A1 - Procedimiento para preparar nuevos derivados de 1,4-di-desoxi-1,4-imino-d-arabinitol, sus isomeros opticos y geometricos y sus sales farmaceuticamente aceptables. - Google Patents

Procedimiento para preparar nuevos derivados de 1,4-di-desoxi-1,4-imino-d-arabinitol, sus isomeros opticos y geometricos y sus sales farmaceuticamente aceptables.

Info

Publication number
AR246745A1
AR246745A1 AR90318034A AR31803490A AR246745A1 AR 246745 A1 AR246745 A1 AR 246745A1 AR 90318034 A AR90318034 A AR 90318034A AR 31803490 A AR31803490 A AR 31803490A AR 246745 A1 AR246745 A1 AR 246745A1
Authority
AR
Argentina
Prior art keywords
glycosyl
compound
procedure
optical
eterified
Prior art date
Application number
AR90318034A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of AR246745A1 publication Critical patent/AR246745A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN PROCEDIMIENTO PARA PREPARAR UN COMPUESTO DE FORMULA (I) SUS ISOMEROS OPTICOS Y GEOMETRICOS Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, DONDE N ES CERO, UNO O DOS, R ES UN RADICAL GLICOSILO O UNRADICAL GLICOSILO ETERIFICADO O ACILADO QUE CONTIENE DE 1 A 3 UNIDADES DE HEXOSA O PENTOSA, CONTENIENDO DICHO RADICAL GLICOSILO ETERIFICADO O ACILADO EL RESTO ETER O ACILO EN EL GRUPO HIDROXI LOCALIZADO EN EL ATOMO DE CARBONO ANOMERICO, QUE COMPRENDE CONDENSAR UN COMPUESTO DE FORMULA (II), CON UN COMPUESTO DE FORMULA (III), DONDE X ES UN HALURO O TRIFLATO, N ES CERO, UNO O DOS, R' ES UNRADICAL GLICOSILO HIDROXI-PROTEGIDO O UN RADICAL GLICOSILO ETERIFICADO O ACILADO DE 1 A 3, HEXOSAS O PENTOSAS, CONTENIENDO DICHO RADICAL GLICOSILO ETERIFICADO O ACILADO EL RESTO ETER O ACILO EN EL GRUPO HIDROXILO LOCALIZADO EN EL ATOMO DE CARBONO ANOMERICO PARA PRODUCIR UN COMPUESTO DE FORMULA (IV), COMPUESTO QUE SE DESPROTEGE POR TECNICA DE DESPROTECCION CONVENCIONALES, SEGUIDO DE UNA CONVERSION OPCIONAL ENÑ UNA SAL DEL MISMO FARMACEUTICAMENTE ACEPTABLE.
AR90318034A 1989-10-10 1990-10-09 Procedimiento para preparar nuevos derivados de 1,4-di-desoxi-1,4-imino-d-arabinitol, sus isomeros opticos y geometricos y sus sales farmaceuticamente aceptables. AR246745A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89402794A EP0422307A1 (en) 1989-10-10 1989-10-10 Novel alpha-glucosidase inhibitors

Publications (1)

Publication Number Publication Date
AR246745A1 true AR246745A1 (es) 1994-09-30

Family

ID=8202997

Family Applications (1)

Application Number Title Priority Date Filing Date
AR90318034A AR246745A1 (es) 1989-10-10 1990-10-09 Procedimiento para preparar nuevos derivados de 1,4-di-desoxi-1,4-imino-d-arabinitol, sus isomeros opticos y geometricos y sus sales farmaceuticamente aceptables.

Country Status (21)

Country Link
US (1) US5097023A (es)
EP (2) EP0422307A1 (es)
JP (1) JP3032266B2 (es)
KR (1) KR0183012B1 (es)
CN (1) CN1029974C (es)
AR (1) AR246745A1 (es)
AT (1) ATE109153T1 (es)
AU (1) AU632855B2 (es)
CA (1) CA2027276C (es)
DE (1) DE69011033T2 (es)
DK (1) DK0422975T3 (es)
ES (1) ES2060980T3 (es)
FI (1) FI101796B (es)
HU (1) HU209724B (es)
IE (1) IE64079B1 (es)
IL (1) IL95928A (es)
NO (1) NO174203C (es)
NZ (1) NZ235578A (es)
PT (1) PT95547B (es)
TW (1) TW225539B (es)
ZA (1) ZA907936B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504078A (en) * 1990-06-08 1996-04-02 Merrell Dow Pharmaceuticals Inc. α-glucosidase inhibitors
US5268364A (en) * 1991-12-12 1993-12-07 The Biomembrane Institute Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by O-glycosylation modification
US5843921A (en) 1994-03-15 1998-12-01 Childrens Hospital Of Los Angeles Therapeutic food composition and method to diminish blood sugar fluctuations
US5605893A (en) * 1994-03-15 1997-02-25 Children's Hospital Of Los Angeles Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
JP3580900B2 (ja) * 1995-04-20 2004-10-27 ホクレン農業協同組合連合会 α−グルコシダーゼ阻害剤を含む糖を主体とする組成物を有効成分とする食品及び飼料
US5929037A (en) * 1995-06-07 1999-07-27 Alberta Research Council Modified α-D-Glcρ-(1-2)-α-D-Glcρ-(1-3)-α-D-Glcρ-analogues
EP1040827A3 (en) * 1995-09-08 2000-10-11 Novo Nordisk A/S Use of 2-alkylpyrrolidines for the treatment of diabetes
US5981720A (en) * 1996-09-09 1999-11-09 Wisconsin Alumni Res Found Human salivary proteins and fragments thereof having alpha-glucosidase inhibitory activity
US6534487B1 (en) 1999-08-03 2003-03-18 Childrens Hospital Los Angeles Methods for suppressing appetite and enhancing exercise and recovery
RU2002119425A (ru) * 1999-12-21 2004-01-10 Адзиномото Ко., Инк. (Jp) Частичный сложный эфир азотистой карбоновой кислоты с целлюлозой и способ его получения
JP4486792B2 (ja) * 2003-06-12 2010-06-23 学校法人近畿大学 環状オニウム化合物およびグルコシダーゼ阻害剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.

Also Published As

Publication number Publication date
KR910007951A (ko) 1991-05-30
ATE109153T1 (de) 1994-08-15
HU209724B (en) 1994-10-28
PT95547B (pt) 1998-02-27
DK0422975T3 (da) 1994-08-22
EP0422975B1 (en) 1994-07-27
NZ235578A (en) 1992-10-28
HUT55402A (en) 1991-05-28
NO174203C (no) 1994-04-06
FI101796B1 (fi) 1998-08-31
CN1029974C (zh) 1995-10-11
EP0422307A1 (en) 1991-04-17
JP3032266B2 (ja) 2000-04-10
NO904372D0 (no) 1990-10-09
ZA907936B (en) 1991-08-28
DE69011033D1 (de) 1994-09-01
DE69011033T2 (de) 1994-11-17
AU6375690A (en) 1991-04-18
EP0422975A1 (en) 1991-04-17
NO174203B (no) 1993-12-20
KR0183012B1 (ko) 1999-04-01
NO904372L (no) 1991-04-11
PT95547A (pt) 1991-08-14
CA2027276C (en) 2000-05-16
JPH03127797A (ja) 1991-05-30
TW225539B (es) 1994-06-21
US5097023A (en) 1992-03-17
FI101796B (fi) 1998-08-31
HU906389D0 (en) 1991-04-29
FI904965A0 (fi) 1990-10-09
IL95928A (en) 1994-08-26
CA2027276A1 (en) 1991-04-11
IE64079B1 (en) 1995-07-12
IL95928A0 (en) 1991-07-18
IE903613A1 (en) 1991-04-24
AU632855B2 (en) 1993-01-14
CN1050879A (zh) 1991-04-24
ES2060980T3 (es) 1994-12-01

Similar Documents

Publication Publication Date Title
IL75337A (en) Polyenoic acids omega-substituted by a 4,5-dimethoxy-2-methyl-quinone or a 4,5-dimethoxy-2-methyl-phenyl group,process for the preparation thereof and pharmaceutical compositions containing the same
BE904431A (fr) Nouveaux derives morpholino de la daunorubicine et de la doxorubicine.
KR830000911A (ko) X-선 콘트라스트제제의 살균된 주사용의 생리적으로 가능한 용액의 제조방법 및 x-선콘트라스트 제제 및 완충액
KR850003503A (ko) 갱글리오사이드 및 그 유도체의 흡입투여 키트와 이에 적합한 약제 조성물
SE8204918D0 (sv) Nya 3-amino-pregn-5-en-derivat, deras salter, sett for framstellning och anvendning derav som lekemedel och kompositioner innehallande dem
SE8801514D0 (sv) Farmaceutisk komposition
FR2506772A1 (fr) Glycosides d'anthracycline, procede pour les preparer et leur usage comme medicament
DK321283A (da) Hidtil ukendte carbacykliner, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
ES2006488A6 (es) Un procedimiento para la preparacion de un glicosido de antraciclina.
ES2032335T3 (es) Nuevos derivados flavonoides 2-piperazinil-2-oxo-etilen sustituidos, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
HUP0001827A2 (hu) Kolchicin-származékok, eljárás előállításukra, valamint ezeket tartalmazó gyógyszerkészítmények, és a vegyületek alkalmazása gyógyszerkészítmények előállítására
KR910007951A (ko) α-글루코시다제 억제제
KR960704904A (ko) 수용성 레티노이드 (Water-soluble retinoids)
ATE36539T1 (de) Antitumor-anthracycline.
SE7714464L (sv) Glykosider och forfarande for framstellning derav
PT91323A (pt) Processo para a preparacao de glicosidos antraciclinicos, de antraciclinonas 4-substituidas intermedias e de composicoes farmaceuticas que os contem
SE8804037D0 (sv) Nya 4-demetoxiantracyclinderivat
IT1232343B (it) Derivati idrosolubili di bioflavonoidi di glicosidici, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
KR880001690A (ko) 바이러스 복제 및 바이러스 병의 억제 방법
GB1497407A (en) Therapeutic compositions
SE7708452L (sv) Komposition innehallande en antrakinonforening
SE8300324D0 (sv) Daunorubicin och doxorubicin-analoger, deras framstellning och anvendning
Glaudemans The specific substance from Diplococcus pneumoniae type 34 US type 41).: Synthesis of methyl 3-O-β-d-galactofuranosyl-α-d-glucopyranoside
SE8206129D0 (sv) Tioalkanoyl-karnitiner, forfarande for deras framstellning och mukolytiska farmaceutiska kompositioner innehallande desamma
FI842742A0 (fi) 15,16-metylen-17 -pregna-4,6-dien-21- karboxylsyrasalter, dessa innehaollande farmaceutiska produkter och foerfarande foer deras framstaellning.